Freek Blanken is a pharmaceutical quality consultant specializing in CAR-T, Advanced Therapy Medicinal Products (ATMPs), vaccines, and biologicals. They hold a PhD in Tumor Genetics from Leiden University Medical Center and have amassed extensive experience in scientific and analytical roles across various organizations, including Batavia Biosciences, Kite Pharma, and Galapagos. Currently, Freek consults for Pharma Diversity while also engaging in projects as a Consultant at Bristol Myers Squibb. Their academic foundation includes a cum laude Master's degree in Biomedical Sciences from Leiden University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices